Patent · US Active

Threonine synthase from nicotiana tabacum and methods and uses thereof

US10501732B2 · kind B2 · utility

1Cited by

1References

16Claims

0Family size

Assignee

Philip Morris Products S.A. · CH

Inventors

Lucien Bovet · La Chaux-de-Fonds, CH
Nicolas Sierro · Neuchâtel, CH

Key dates

Filing date	Aug 31, 2012
Grant date	Dec 10, 2019
Priority date	—
Expiry date	Aug 31, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y402/03001
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

There is disclosed a mutant, non-naturally occurring or transgenic plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a threonine synthase and having at least 90% sequence identity to SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3 or at least 87% sequence identity to SEQ ID NO:4, or SEQ ID NO:5; (ii) a polypeptide encoded by any one of said polynucleotides set forth in (i); or (iii) a polypeptide having at least 95% sequence identity to SEQ ID NO:6, SEQ ID NO:7 or SEQ ID NO:8; or (iv) a construct, vector or expression vector comprising the polynucleotide as set forth in (i).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.